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Summary/Abstract
Differential protein precipitation is a rapid and economical step in protein purification and is
based on exploiting the inherent physicochemical properties of the polypeptide. Precipitation of
recombinant proteins, lysed from the host cell, is commonly used to concentrate the protein of
choice before further polishing steps with more selective purification columns (e.g. His-Tag,
Size Exclusion etc.). Recombinant proteins can also precipitate naturally as inclusion bodies due
to various influences during over-expression in the host cell. Although this phenomenon permits
easier initial separation from native proteins, these inclusion bodies must carefully be
differentially solubilised so as to reform functional, correctly folded proteins. Here, appropriate
bioinformatics tools to aid in understanding a protein’s propensity to aggregate and solubilise are
explored as a backdrop for a typical protein extraction, precipitation and selective
resolubilisation procedure, based on a recombinantly expressed protein.
Key Words
Ammonium Sulphate precipitation, Bioinformatics, Inclusion body solubilisation, Protein
refolding, Trichloroacetic Acid precipitation, Three Phase precipitation.

1.

Introduction

Protein precipitation can be caused by the differential solubility between a protein-rich soluble
phase and a solid chemical precipitant. Soluble proteins can be insolubilised by interaction with a
suitable precipitant that decreases the protein’s attraction to the solvent and increases the
protein’s attraction to other protein molecules, resulting in protein accumulation and eventually
precipitation. The addition of low molecular weight substances, such as glycerol, polyethylene
glycol and sucrose, and high molecular weight substances such as serum albumin, can have
significant effects on protein structure and stability. Preferential hydration of a protein molecule
caused by the presence of these additives can increase the protein’s stability. Certain salts can
also exert a stabilising effect by ‘salting out’ hydrophobic residues of a protein, causing the
molecule to adapt a more compact, stable structure (1) frequently resulting in precipitation. The
use of such protein precipitating molecules is an empirical process, the effects of any given
substance on a protein must be determined experimentally. The use of additives can not only be
used as a simple approach to increase the stability of a given protein, but also to actively effect
protein precipitation. Protein precipitation can be used as a crude protein clean-up method from
cell lysates, readily employed after bacterial over-expression of recombinant proteins.
Differential solubilisation of proteins is often employed for proteomic analyses (2, 3), but it too
can offer an alternative purification technique for non-soluble recombinant proteins expressed in
heterologous hosts. Recombinant proteins expressed as inclusion bodies can be readily separated
from the host cell protein matrix, however careful solubilisation and refolding are critical for
obtaining suitable recombinant proteins for further downstream processes.

Protein modelling and in silico analysis can assist in the experimental design process, for
example, in reducing the empirical experimentation required. Bioinformatic analyses can be
undertaken to gain an understanding of the physicochemical properties of the target protein (e.g.
amino acid composition, secondary structure prediction) and its propensity to aggregate at the
outset of a protein expression project. The solubility of a protein upon expression is heavily
dependent on its primary amino acid sequence and initial solubility prediction methods were
based on the content of charged and turn-forming residues. In recent years, more advanced
prediction software has been developed utilising training sets of soluble and insoluble proteins.
These tools are used to predict solubility before performing wet lab experiments thus saving
effort, time and cost [recently reviewed elsewhere; (4)].
By way of a worked example, a typical recombinant protein precipitation and resolubilisation
procedure, preceded by judicious bioinformatic analyses, is outlined.

2.

Materials

Notes:

2.1

1.

All consumables may be sourced from Sigma-Aldrich unless otherwise stated.

2.

A computer and Internet access is all that is required for bioinformatic analyses.

Recombinant / Native Protein Extraction.

•

Centrifuge (Bucket Type, e.g. J2-21, Beckman and microfuge, e.g. 5415D
Eppendorf).

2.2

•

pH meter (e.g. M-240, Corning).

•

Sonicator (e.g. Vibra Cell, Sonics Scientific).

•

Water bath (temperature controlled).

•

Vortex.

•

Resuspension Buffer One: 50 mM Na2HPO4-NaH2PO4, pH 8.0, 0.3 M NaCl.

•

-80 oC freezer

Protein Precipitation using Ammonium Sulphate.
•

Resuspension Buffer One: 50 mM Na2HPO4-NaH2PO4, pH 8.0, 0.3 M NaCl.

•

Saturated Ammonium Sulphate: Add 750 g of (NH4)2SO4 to 1 L of double distilled
water in a beaker or flask. Stir the solution at room temperature with a magnetic
stirrer for 15 min or until saturation. Gently decant the clear supernatant solution
after the undissolved solids settle on the bottom of the flask.

•

2.3

Graduated Pipette (10 mL).

Protein Precipitation using Trichloroacetic acid.
•

2% Deoxycholate (DOC): Add 2 g of DOC to 100 mL of double distilled H2O, mix
well.

•

100% Trichloroacetic acid (TCA): Add 1 g of TCA to 454 µL double distilled H2O
and mix carefully. Store in a light proof bottle at 4oC until required for use. TCA is
a harmful skin and eye irritant. Always use correct personal protective equipment
when handling it.

•

Acetone (ice cold). Store acetone at -20oC. Use directly from -20oC.

•

Vacuum Dryer (e.g. DNA 110 Speed Vac, Savant)

•

Resuspension Buffer: 50 mM Na2HPO4-NaH2PO4, pH 8.0, 0.3 M NaCl.

•

Centrifuge (Bucket Type, e.g. J2-21, Beckman and microfuge, e.g. 5415D
Eppendorf).

2.4

Protein Precipitation using Three Phase Partitioning.
•

Saturated ammonium sulphate (see Section 2.2).

•

t-Butanol (HPLC grade).

•

Aspirator (e.g. FB70155, Fisherbrand) or siphon tube.

•

Centrifuges (Bucket Type, e.g. J2-21, Beckman; microfuge, e.g. 5415D Eppendorf).

2.5 Protein Solubilisation.
•

DNase I (100 U/mL).

•

Resuspension Buffer Two: 50 mM Na2HPO4-NaH2PO4, pH 8.0, 0.3 M NaCl, 5mM
DTT (see Note 1), 0.35 mg/mL Lysozyme, Proteinase Inhibitor Cocktail (see also
Chapter 4). Make up as fresh prior to use.

•

Triton X-100.

•

Solubilisation Buffer: 50 mM Na2HPO4-NaH2PO4, pH 8.0, 0.3 M NaCl, 25 mM
DTT, 6 M Guanidine HCl.

2.6

•

PBS-T: Phosphate buffered saline (PBS, 1x) containing 1% (v/v) Triton X-100.

•

Centrifuges (Bucket Type, e.g. J2-21, Beckman; microfuge, e.g. 5415D Eppendorf).

•

Vacuum Concentrator (Speed Vac, Savant)

Protein Refolding.
•

Refolding Buffer: 50 mM Na2HPO4-NaH2PO4, pH 8.0, 0.3 M NaCl, 2.5 mM
reduced Glutathione, 0.25 mM Oxidized Glutathione, 0.2 M Arginine.

•

Dialysis Buffer: 50 mM Na2HPO4-NaH2PO4, pH 8.0, 0.3 M NaCl.

•

Dialysis apparatus (dialysis tubing and clips, magnetic mixer, large clean
container).

•

Guanidine Hydrochloride: 6 M stock, made in double distilled H2O.

•

Amicon protein concentration device (e.g. Ultra-15 Centrifugal Filter Units,
Amicon).

•

Gradient maker apparatus (see Fig. 1).

3.

Methods

3.1 Computational prediction of protein solubility
1. Obtain the protein of interest’s Accession number (a unique identifier) and its amino
acid

sequence

(in

FASTA

format)

by

searching

the

Uniprot

database

(www.uniprot.org).
2. Use TMHMM 2.0 (http://exon.niaid.nih.gov/cas/manual/TMHMM.html) or another
membrane protein webserver to predict the protein’s secondary structure and whether it
is expected to be membrane bound.
3. If the protein of interest is not a membrane protein, utilise PROSO II (PROtein
SOlubility: http://mips.helmholtz-muenchen.de/prosoII; 5) or ESPRESSO (EStimation
of PRotein ExpreSsion and Solubility: http://mbs.cbrc.jp/ESPRESSO/Submission.php;
6) to classify the protein as soluble or insoluble (see Notes 2 and 3).
3.2 Optimisation of protein solubility
After bioinformatic analysis, if the protein is predicted to be insoluble this could result in
unwanted precipitation. An approach towards preventing this is through random or rational
mutagenesis of specific codons to enhance solubility (see Note 4).
1. Search the Protein Databank (PDB, http://www.rcsb.org/pdb/home/home.do) for a
structure (crystal/nuclear magnetic resonance) of the protein of interest and download
the relevant PDB file. If a template structure is unavailable, a comparative model may
be available (e.g. ModBase, http://modbase.compbio.ucsf.edu/modbase-cgi/index.cgi).

2. Visualise the protein structure using suitable software, for example, Pymol software
(www.pymol.org) or Swissprot Viewer (http://spdbv.vital-it.ch/).
3. Analyse solvent accessible residues and determine possible hydrophobic surface amino
acids for mutation (see Note 5).
4. Design a mutated gene for improved protein solubility (see Note 6). Translation
software such as GeneDesigner (https://www.dna20.com/resources/genedesigner) is
available to aid in this process (7).

3.3

Recombinant / Native Protein Extraction.
The source of the protein will determine the optimal technique to release the protein from
the tissue or cells in which it is contained. The typical freeze-thaw cell lysis procedure
(below) is generally sufficient to lyse most bacterial cell types although other options are
available (see Notes 7, 8, 9).
1.

Collect the bacterial cells by transferring the bacterial culture to a pre-chilled
sterile centrifuge tube and centrifuge at low speed (5 min, 800 x g) in a previously
cooled centrifuge (4°C).

2.

Carefully remove the culture media from the bacterial cell pellet, ensuring the
pellet is not disturbed.

3.

Resuspend the cell pellet in Resuspension Buffer One, in 10% of the original
culture volume (see Note 10).

4.

Freeze the resuspended cells to -80oC by placing the resuspension solution (still in
the plastic centrifuge tube) into a pre-equilibrated -80oC freezer (or liquid
Nitrogen), then warm the cells to 37oC (using a pre-equilibrated water bath) for 10
min. Repeat this freeze thaw process three times (see Note 11).

Sonication can also be used if the protein is not released during the freeze thaw steps. It is
crucial to maintain the cell suspension on ice during the sonication process (see Notes 12,
13, 14).
5.

Sonicate at 10 amplitude microns for 10-20 s.

6.

Allow the cell suspension to stand on ice for 30 s.

7.

Repeat steps 5 and 6 three more times.

8.

Check the recombinant protein induction/expression by loading and analysing a
representative sample (typically 50 µg protein) onto a sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) gel (see Note 15).

3.4

Protein Precipitation using Ammonium Sulphate.
A common and inexpensive first step to isolate and concentrate proteins during protein
purification is precipitation with an external additive. This additive alters the
physicochemical properties of the protein causing it to fall out of solution. Selecting a

precipitating agent is a matter of identifying the one that provides the desired protein in the
most optimal final state. Ammonium sulphate (see Note 16) is commonly used for largescale precipitations.
1.

Gently stir the protein mixture with the aid of a magnetic stirring bar at 4 oC. Add,
using a graduated pipette, the saturated ammonium sulphate solution drop-wise to
the protein solution until precipitates start to form (see Notes 17, 18 and 19).

2.

Once sufficient saturated salt solution has been added to cause precipitation of the
protein of interest (indicated by collection of precipitate at the bottom of the
container), centrifuge the mixture at 10,000 g for 15 min in a pre-cooled rotor.
Collect the precipitate by carefully discarding as much supernatant as possible
(see Note 18).

3.

Resuspend the protein pellet at 4oC in Resuspension Buffer One for further
downstream processes (see Notes 20 and 21).

3.5

Protein Precipitation using Trichloroacetic acid.
Trichloroacetic acid (TCA) is routinely employed for small-scale operations or
precipitations of protein preparations that are at low concentration; however, it should be
noted that this procedure is protein denaturing, and caution must be exercised when
working with TCA (see Notes 22, 23, 24).

1.

To one volume of protein solution, add 1/100 volume of 2% DOC (sodium
deoxycholate).

2.

Vortex and incubate for 30 min at 4oC.

3.

Add 1/10 volume of 100% Trichloroacetic acid (TCA). Vortex the solution and
incubate statically overnight at 4oC.

4.

Centrifuge the sample for 15 min at 4oC (10,400 x g). Gently remove the
supernatant and retain the pellet. Carefully dry the tube by inversion on tissue
paper (note: the pellet may be difficult to see).

5.

Optional: Wash the pellet twice with one volume of ice-cold acetone. Vortex and
re-pellet the samples by centrifugation 10,400 x g for 5 min at 4oC between
washes (see Note 24).

6.

Dry the samples under vacuum (e.g. Speed Vac, Savant) or allow to air dry.

7.

Resuspend the protein pellet in a buffer of choice for further downstream
processes.

3.6 Protein Precipitation using Three Phase Partitioning (TPP)
TPP is a three-stage batch method, which is a hybrid of salting out and alcohol
precipitations. Its key advantages are that a lower concentration of ammonium sulphate is
required and the technique can be performed at room temperature (see Note 25).

1. Whole cells are treated with aqueous 1.6 M ammonium sulphate solution buffered at
pH 8.0 with 50 mM Tris-HCl, pH 8.0, with shaking.
2. Add 1 volume of tertiary butanol (t-butanol). Shake vigorously for 1 min at room
temperature (RT).
3. Centrifuge (10,000 x g) for 15 min at room temperature. Three phases separate during
centrifugation.
4. Remove the upper (alcohol) layer by aspiration (see Note 26). Remove the lower
precipitate layer, leaving the interfacial aqueous layer.
5. Fresh t-butanol is added to the remaining aqueous layer (with vigorous shaking once
again)
6. Precipitation again and collect layers as above.
7. Add ammonium sulphate to the precipitate layer (see Section 3.4).
8. Resuspend the protein pellet at 4 oC in Resuspension Buffer One for further
downstream processes.

3. 7

Protein Solubilisation.
Recombinant protein expression in a heterologous host frequently can result in insoluble
and inactive proteins (see Note 27). Regularly, protein overexpression results in the
production of inclusion bodies, which are insoluble aggregates of misfolded protein.
Although these inclusion bodies can be purified, further characterisation of this protein
mass is often impossible without solubilisation of the protein of interest and refolding
into an active form (see Note 28). A typical inclusion body solubilisation, using Triton

X100 as a detergent, and refolding protocol is outlined below (see also Note 29). An
additional detergent screening methodology, to identify superior alternatives to Triton
X100, is also detailed.
1. Carry out steps 1-3 as outlined in Section 3.3, except resuspend the cell pellet in 10%
of the original culture volume of Resuspension Buffer Two.
2. Slowly add Triton X-100 (to a final concentration of 1% v/V), and mix gently (see
Note 30 and Section 3.7.1).
3. Carry out the sonication procedure as outlined in Section 3.3, steps 5 -7.
4. Incubate the cell debris with DNase I (100 U/mL) for 1 h at 37 oC.
5. Collect the inclusion bodies by centrifugation at 30,000 x g for 30 min at 4 oC.
6. Wash the inclusion body pellet twice with PBS-T, followed by centrifugation at
30,000 x g for 30 min at 4 oC.
7. Solubilise the pelleted inclusion bodies in the solubilisation buffer and allow total
solubilisation to occur at 4 oC for 1 h, with occasional gentle mixing.
8. After 1 h solubilisation, remove all remaining insoluble material by centrifugation
30,000 x g for 10 min at 4 oC (see Note 31).
9. Determine the protein concentration and adjust to 1 mg/mL by dilution in
solubilisation buffer and proceed directly to re-folding at 4 oC (Section 3.8).

3.7.1

Protein Solubilisation Detergent Screen
Selecting the appropriate detergent can be crucial for effective purification, particularly of
membrane proteins. An additional detergent screening methodology is provided if
required.
1.

Lyse cells as previously described. A membrane preparation may be performed if
required (see Note 32).

2.

Small aliquots of lysed cells/cellular membranes are mixed with an equal volume
of Resuspension Buffer Two containing different detergents (e.g. DDM, LDAO,
DM, FC-12, C12E9; see reference 8). To avoid the production of foam, do not
vortex the solubilisation mixtures but mix by gently pipetting up and down.

3.

Gently mix using an end-over-end rotator at 4 oC for 12–14 h (see Note 33).

4.

Take a 10 µL sample for analysis by SDS-PAGE and store at 4 oC.

5.

To pellet the unsolubilized material, centrifuge the remainder of the sample for 30
min at 100,000 x g and 4 oC.

6.

Remove the supernatant from each tube taking care not to disturb the pellet and
transfer it to another clean, chilled 1.5 mL tube.

7.

Mix the contents of each tube by gentle pipetting up and down. Take a 10 µL
sample for analysis by SDS-PAGE.

8.

Examine samples by SDS-PAGE, and Western blot if appropriate, to identify the
detergent and conditions that resulted in the best solubilisation (see Note 34)

9.

Incorporate these detergent and incubation parameters for the purification of the
target protein.

3.8

Protein Refolding.
In recent years there have been many novel approaches developed to induce protein
refolding. These include high hydrostatic pressure (9), dialysis against PE-PEG (10), solidphase refolding in cation-exchange resin with decreasing gradient of urea (11) and the use
of micro-fluidic chips (12). However, one of the most cost effective and easiest to execute
is simple low concentration, gradient dialysis, as detailed below.
1.

Dilute the solubilised proteins as quickly as possible (to yield a final protein
concentration of 0.1 mg/mL, see Note 35) into pre-chilled Refolding Buffer (see
Note 36).

2.

Dialyze the diluted solubilised protein overnight against a 200-fold volume of
dialysis buffer with slowly decreasing concentrations of guanidine hydrochloride
(GuHCl) (typically decrease GuHCl concentration as follows: 6 M, 4 M, 2 M, 1
M, 0.5 M and then 0 M in a continual dialysis approach; see Fig. 1 and Notes 37,
38).

3.

Centrifuge the dialysate at 4 °C for 30 min at 30,000 x g.

4.

Carefully remove the liquid protein rich layer, concentrate (e.g. Amicon filtration)
and store at an appropriate temperature (see Note 39).

5.

To ensure correct protein folding perform an appropriate bioassay and run a
sample on SDS-PAGE.

[Insert Figure 1 here]

Notes
1. If the protein contains cysteine residues, oxidation could lead to protein aggregation. A
reducing agent, such as DTT, is added to the buffer to prevent this.
2. PROSO II is a machine-learning model trained on an experimentally available dataset of
proteins. This is a public webserver to classify proteins into “soluble” and “insoluble” classes.
ESPRESSO implements both a sequence/predicted structural property-based method and a
sequence pattern based method to predict protein solubility.
3. If the protein is predicted as being soluble, proceed with recombinant expression and
purification; if predicted as being insoluble, mutagenesis (Section 3.2) is an option or the protein
can be expressed insolubly and resolubilised (Section 3.3 onwards).
4. In general, the amino acids on the protein’s surface (those not affecting function) are primary
mutagenesis targets, with the mutagenic approach taken to minimise the weak interactions that
result in inclusion body formation. This is typically achieved by replacing the hydrophobic

surface amino acid residues with charged, polar hydrophilic or less hydrophobic residues (13).
The success of rational molecular engineering depends on the availability of a suitable resolution
3D structure of the candidate protein for selection of the surface residues to mutate.
5. Computational prediction of a proteins aggregation propensity is based on its amino acid
sequence. Available analysis tools include AGGRESCAN (http://bioinf.uab.es/aggrescan/) or
AMYLPRED2 (http://biophysics.biol.uoa.gr/AMYLPRED2). Molecular engineering, such as the
addition of a translation fusion Green Fluorescent Protein (GFP) tag for example, can facilitate
easier downstream analysis through florescence detection (14).
6. Alternatively, an approach is to determine folding free-energy estimations of proposed
mutated structures and focus on those site mutations likely to enhance solubility e.g. PoPMuSiC
software (15; http://dezyme.com/).
7. There are several methods to achieve this, including repeated freezing and thawing,
sonication, homogenization at high pressures, enzymatic lysis or permeabilization by organic
solvents. The method of choice depends on how fragile the protein is and how robust the host
cell is (16). Commonly cited examples of cells with modified robustness include the use of easily
lysed E. coli expression cell lines (e.g. pLYSs mutants or alternative mutants; 17) or wall-less
strains, L-form strains, lpp deletion strains and the use of co-expression of lysis-promoting
proteins (18). The use of molecular engineering to introduce a signal peptide (e.g. pelB from
Pectobacterium carotovorum, formally known as Erwinia carotovora, or SP from Bacillis; 19)
may also offer a method to direct protein expression to an easily extracted portion of the
fermentation. Methods of extraction from the various cellular, and extra cellular, compartments
are detailed in Notes 8 and 9. Molecular methods can be further enhanced by simple inclusion of

specific additives and compounds to increase targeted protein accumulation (20) and
downstream solubility (21).

8. Proteins can also be selectively released from the various compartments of a bacterial host, for
example proteins expressed in the periplasmic envelope can be selectively lysed by a method
similar to that described by French and co-workers (22). Pellet the bacterial cells to be disrupted
by centrifugation at 800 x g for 3 min. Resuspend the pellet in Fractionation Buffer (F1) buffer in
20% of the original culture volume. The F1 comprises (final concentrations): 500 μg/mL
lysozyme, 20% w/v sucrose, 1 mM EDTA, pH 8.0, 200 mM guanidine hydrochloride and 200
mM Tris-HCl, pH 8.0, at room temperature. Statically incubate the resuspended cells at room
temperature for 15 min, after which add an equal volume of ice-cold water. Stand the mixture at
room temperature for 15 min. Remove the cell debris by centrifugation at 10,400 x g for 10 min.
Transfer the supernatant (containing the periplasmic fraction) to a clean container for further
purification.
9. Proteins expressed and transported to the culture supernatant can also be conveniently
concentrated by a method outlined by Caldwell and Lattemann (23). In brief this method
involves adding an equal volume of a PRMM solution (0.05 mM pyrogallol red, 0.16 mM
sodium molybdate, 1.0 mM sodium oxalate, 50.0 mM succinic acid, 20% v/v methanol in H2O,
adjusted to pH 2.0 with HCl) to cleared (0.22 µm filtered) culture supernatant. Adjust the pH of
the solution to 2.8 (±0.1), and allow the proteins to precipitate for 1 to 2 h at room temperature,
followed by an overnight incubation at 4°C. Sediment the precipitate by centrifugation at 10,000
x g for 1 h, and carefully remove the supernatant. Repeatedly rinse the precipitate with 1 mL of

acetone. Remove all traces of acetone by evaporation at room temperature. Solubilise the
precipitate by adding 100 µL of 2x SDS-PAGE sample buffer (25% glycerol, 8% SDS, 4% βmercaptoethanol, 0.02% bromophenol blue, 100 mM Tris-HCl, pH 6.8). These samples can be
applied directly to an SDS-PAGE gel, if this type of analysis is required.
10. A protein is least soluble when at its isoelectric point (pI). Hence, selection of an appropriate
pH buffer range is important e.g. Hepes (pH 6.8-8.2); Tris-HCl (pH 7.5-9); phosphate (pH 5.88). To determine a given protein’s pI, its accession number (or amino acid sequence in FASTA
format) should first be retrieved from the Uniprot database (www.uniprot.org). Subsequently a
webserver such as the bioinformatics resource portal can be utilised to determine a theoretical pI
(http://web.expasy.org/compute_pi/) and aid in appropriate buffer selection (e.g. choose a pH
buffer one unit above or below the pI of the protein of interest).
11. If the expression host of choice is a yeast, one of the most widely used methods for the
disruption is agitation with glass beads. Several cycles of agitation are interspersed with cooling
cycles to avoid overheating.
12. The sonication process can generate large amounts of heat, which is why pulses are limited to
~20 s. In between pulses, cool the tube in ice or ice-water slurry for 30 s. If a large volume is
required to be sonicated, split the cell suspension into two tubes, and alternate the sonication and
cooling steps. Sonicate on ice where possible in order to maintain protein activity (24, 25) during
sonication. See reference (26) for an in-depth review of sonication optimisation during
recombinant protein lysis.

13. The extraction process also releases proteases, which will digest all proteins in the solution.
If the protein is sensitive to proteolysis, it is desirable to employ a protease inhibitor (see
Chapter 4), to proceed quickly, to keep the extract cooled to minimise proteolysis and to select
an easily lysed cell line that is ideally protease-deficient (see Note 7).
14. Lysozyme (500 μg/mL, to assist cell wall degradation) and DNase I (100 U/mL, to degrade
genomic DNA) can be added to the lysis buffer.
15. An alternative approach to quantify protein induction and over expression is to use a
Nanodrop spectrophotometer (Thermo Scientific). Similar to a SDS-PAGE gel analysis it is best
to compare an expressed sample lysate against a replicate non-induced sample as a control. If the
protein of interest is catalytically active a crude lysate test of functional activity, or an
appropriate bioassay may also give an indication of successful over expression and cell lysis.
16. The addition of high concentrations of salt to a protein solution causes precipitation by
removing water from hydrophobic patches on the protein’s surface, resulting in these patches
aggregating together causing the protein to come out of solution. A number of salts can be used
for this process; NaCl, Na2SO4, KCl, CaCl2 and MgSO4, however, (NH4)2SO4 is by far the most
commonly used additive. This is due to several advantageous characteristics of the salt, including
the fact that it has a high solubility in water (4 M saturation) and it has a low density at saturation
allowing precipitated proteins to be collected by centrifugation. Hence the first proteins to be
purified during ammonium sulphate precipitation are water-soluble proteins (27). Alternatively,
an empirically derived dual additive approach can also enhance selective protein precipitation
based on the synergistic effect of electrostatic interactions in combination with traditional
salting-out effects (28).

17. The concentration of ammonium sulphate needed for precipitation varies from protein to
protein and is dependent on salt/protein concentration, pH, temperature and time. It should be
determined empirically (29). In brief, this entails placing a volume of cell extract, e.g. 10 mL,
into each of 5 test tubes. Adding, with gentle mixing, amounts of solid ammonium sulphate to
yield 20 %, 30 %, 40 %, 50 % and 60 % w/v saturation and allowing to sit for 30 min to promote
precipitation. The insoluble material is collected by centrifugation and the resulting pellets
dissolved in an appropriate buffer, dialysed if required, and assayed for enzyme activity or
analysed by SDS-PAGE.
Final concentrations of ammonium sulphate must be calculated using standard nomograms or
with

online

tools

(“Ammonium

Sulfate

Calculator”,

available

at

www.encorbio.com/protocols/AM-SO4.htm). Adding increasing amounts of ammonium sulphate
causes the different fractions of a protein mixture to precipitate at different rates. One advantage
of this method is that it can be performed inexpensively with very large volumes. Additionally,
the high salt content of the precipitated protein permits its direct addition onto a hydrophobic
interaction chromatography (HIC) purification column, thus speeding up the overall purification
process.
18. Ammonium sulphate salt can be added either in saturated solution or directly as salt crystals.
It may be advantageous to add pre-ground ammonium sulphate directly into the protein mixture
as powdered solids during large-scale purification processes so that the effect of dilution by the
salt solution is minimized. If a saturated salt solution is employed the amount of ammonium
sulphate solution added must be recorded accurately, often this is achieved by dispensing from a
graduated pipette. It is critical to avoid the spatial non-uniformity in the salt concentration during

the addition of the salt solution. Localized concentration “hot-spots” will prematurely initiate the
precipitation of other proteins and inadvertently affect the precipitation process. Record the
volume of the saturated ammonium sulphate solution required to precipitate the protein of
interest. Also note that protein precipitation is not instantaneous; it may require more than 30
min to equilibrate.
19. Purification of integral membrane proteins requires the addition of a detergent such as
sodium dodecyl sulphate (1% w/v SDS) to dissolve cell membranes and keep membrane proteins
in solution during purification. It should be noted that SDS causes protein denaturation, hence
milder detergents such as 1% Triton X-100 or 1% CHAPS can be used to retain the protein's
native conformation during cell membrane dissolution.
20. Avoid frothing (as much as possible) when mixing, as air can promote oxidation of proteins
and also cause protein denaturation at the air-water interface.
21. For many downstream processes it is important to de-salt and to remove/inhibit proteases
(see Chapter 4) to avoid protein degradation. Alternatively, this salt rich preparation can be
applied directly onto a hydrophobic interaction chromatography column, followed by a size
exclusion column to effect purification and simultaneously remove precipitating salt (see Note
17).
22. TCA is a harmful skin and eye irritant. Always use correct personal protective equipment
when handling it.
23. There are numerous options to effect other types of protein precipitation including (but not
limited to) acetone precipitation (useful to simultaneously eliminate acetone soluble components

and increase protein concentration), ethanol precipitation (useful to simultaneously concentrate
proteins and remove traces of GuHCl prior to SDS-PAGE analysis), acidified acetone/methanol
(50/50 v/v; useful to simultaneously remove acetone and methanol soluble interferences such as
SDS prior to IEF analysis) and chloroform/methanol (50/50 v/v; useful to simultaneously remove
salt and detergents).
24. The presence of trace amounts of TCA, carried through from the precipitation, can acidify
the resuspension sample buffer. If further downstream processes are pH sensitive the sample
buffer should be titrated with 1 M NaOH or 1 M Tris-HCl, pH 8.5, to obtain the desired pH for
the required process. Acidified SDS-PAGE sample buffer, for example, can give a yellow
colour. Correct titration will result in reversion to the typical blue sample buffer colour. Hint: A
simple method to overcome this is to resuspend the samples in a slightly basic SDS-PAGE
loading buffer (e.g. pH 9.0). Hence, any residual TCA left it will be neutralized by the basic
buffer allowing direct addition onto the SDS-PAGE gel. Additionally, excess TCA traces will
cause the Coomassie dye to precipitate during SDS-PAGE. If this is a problem repeat the
optional wash steps outlined.
25. Recently Three Phase Fractionation, and derivatives such as Ionic liquid-based three phase
partitioning, have been cited as effective alternatives both singularly (30) or as part of a
combination approach such as preparative crystallisation (31). Three Phase Partitioning utilises
saturated, buffered ammonium sulphate in combination with an equal volume of water miscible
aliphatic alcohol, commonly t-butanol. The two solutions do not mix and a heterogeneous, twophase liquid is produced that can be used to partition proteins from whole cells without the need

to pre-lyse the cells. This process can be readily scaled-up for larger scale protein production and
precipitation.
26. Although t-butanol is miscible with water, it is insoluble in aqueous solutions having high
concentrations of salt, especially ammonium sulphate solutions. Three phases separate during
centrifugation. The upper phase contains t-butanol, while the precipitate settles below the organic
layer.
27. Expression of insoluble recombinant proteins has been noted as greater than 30% of all
recombinantly expressed proteins (32).
28. The interactions between solvents and proteins, and also proteins and proteins, determine the
solubility of any given protein. Interactions can be classified as either attractive or repulsive. A
protein will be soluble in a particular solvent if the net free energy of the proteins interactions is
adequately negative (i.e. attractive). Additionally, protein solubility is improved if proteinprotein interactions have sufficiently positive net free energy (i.e. repulsive), although it should
be noted that protein-protein interaction is modulated by the chemical nature of the solvent of
choice. Conversely, insolubility typically results from net attractive forces between proteins and
net repulsive forces between the solvent of choice and the protein of interest. Furthermore, a
soluble protein can be insolubilised by a change in its free energy state in relation to the proteins,
or the solvent, it interacts with and, hence, additions/subtractions to a protein solution should be
carefully assessed on a small scale (33).
29. The separation of one protein, or family of proteins, from other proteins by means of
differential solubility with chemical reagents is based on the differential solubility between a

liquid phase and a solid phase. The optimisation of this procedure is empirical but, Lindwall and
colleagues (34) outline an optimisation procedure based on a sparse matrix approach;
solubilisation buffers are composed based on “solubility space” which is related to accepted
protein solubilisation theories. This method assists in identifying suitable solubilisation
conditions for most over-expressed proteins (see Note 30).
30. Non-ionic detergents such as Triton X-100 are less effective in solubilizing hydrophobic
proteins (35). An initial detergent screen may be required and can be performed to determine the
optimum conditions for both solubilisation efficiency and maintenance of protein function. For
example, during solubilisation a membrane protein is transferred from its natural environment to
a buffered detergent solution. Membrane proteins require detergents for solubilisation during
isolation as well as to maintain solubility.
31. It is important to remove existing aggregates that can act as nuclei to trigger aggregation
during folding.
32. In brief, a typical membrane preparation protocol is as follows. Wash cells of interest three
times with ice cold PBS, and then pellet at 500 x g for 10 min at 4oC. Discard the supernatant
and resuspend the cells in 2 mL hypotonic buffer (10 mM HEPES [pH 7.9], 1.5 mM MgCl2, 10
mM KCl, 0.5 mM DTT, 1X protease inhibitor cocktail containing 50 mM NaF, 2 mM Na3VO4, 1
mM Na4P2O7). Sonciate cells on ice for 1 min. Spin the lysate at 3,000 x g for 15 min at 4 oC, to
remove cell debris. Transfer the supernatant to an Optiseal Polyallomer tube (Beckman 362185)
and fill the tube with the lysate rich hypotonic buffer (fill volume 5 mL) and centrifuge at
100,000 x g for 1 h at 4 oC (in a NVT90 rotor using the Optima L-100 XP Ultracentrifuge,
Beckman Coulter). After centrifugation, remove the supernatant and resuspend the membrane

pellets in 50 µL MES buffer (25 mM MES, 150 mM M NaCl, 1 % Triton X-100, pH 6.5).
Finally, to aid complete solubilisation, sonicate the sample, on ice, for 10 sec.

33. The amount of time necessary for solubilisation may be less than this and can be optimized to
1 h once an appropriate detergent has been selected.
34. Detergent screening can be further facilitated if the recombinant protein of interest is tagged
with GFP.
35. The final protein concentration should not exceed 0.05 to 0.1 mg/mL as dilute protein
mixtures refold optimally at this concentration. A rapid and efficient mix is essential at this step.
Constant literature reviews of the fundamental refolding processes are available; see (36) and
(37) for comprehensive and accessible reviews of refolding solubilised proteins. Cited protocols
range from empirical to rationally designed (38). Alternatively, an open source collection of
protocols, REFOLD, is available at http://refold.med.monash.edu.au/. These are practitioner
derived standard protocols supplemented with hands-on practical considerations (39).
36. The addition of a mild solubilising agent [e.g. 1 M 3(1-pyridinio)-1-propane sulfonate]
during the refolding steps limits re-aggregation of re-folding proteins. For further information on
this, Tsumoto and co-workers (40) compressively detail the effect of small molecule additives
on refolding and aggregation of the proteins along with other considerations for refolding
recombinant proteins.
37. Continual dialysis can be set up by using a gradient maker. In its simplest form, this consists
of two containers of the same shape connected by a siphon. One container contains the low

concentration buffer, and the other contains high concentration buffer. The buffer is withdrawn
from the low concentration container to the high concentration container. This will produce a
linear gradient from high to low buffer concentrations over the total volume of the gradient.
Once the “low concentration buffer” supply has been depleted, the dialysis tubing is removed
from the larger vessel and placed in a similar, clean vessel containing fresh buffer at the same
concentration as the original “low concentration buffer”. The “low concentration buffer” vessel
is replaced with a vessel containing buffer at the next lower concentration level and the process
is allowed to continue until the “low concentration buffer” supply is depleted again. This process
is repeated until the vessel containing the dialysis tubing has reached the desired final
concentration, typically 0 M GuHCl.
38. See Rudolph and Lilie (41) for a comprehensive overview of protein refolding and (42) for
an industrial viewpoint on that topic.
39. Most proteins can be stored at 4°C, without significant denaturation, for up to 24 h. For
intermediate storage times (24 h to one week) the protein should be filter sterilised (through a
0.22 µm filter) and stored at 4°C. Additional supplements, such as a bacteriostatic agent (e.g.
0.1% sodium azide) can be included to avoid bacterial growth. For storage times greater than one
week (up to several months) it is advisable to freeze the protein preparation. Rapid freezing helps
reduce protein denaturation. It is useful to freeze the solution in small aliquots to avoid repeated
freeze/thaw cycles which may reduce the biological activity of the protein. Additional stabilizing
agents can also be added prior to freezing, such as glycerol (5-50% w/v), serum albumin (10
mg/mL), reducing agents (such as 1 mM DTT), and ligands/co-factors (depending on the nature
of the target protein). Extended protein storage (several months to years) should be carried out at

-80°C or in liquid nitrogen. The addition of 50% (w/v) glycerol is recommended for storage at
this temperature. Alternative strategies include storing the protein as an ammonium sulphate
precipitate at 4°C, or at lower temperatures in a lyophilized form (see also Chapter 9 for
protocols and discussion regarding the storage and lyophilisation of proteins).
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Figure legend
Figure 1: Schematic diagram of a simple gradient maker.

